# Effectiveness of a Digital Health Application for Multiple Sclerosis (Levidex)

> **NCT06090305** · NA · COMPLETED · sponsor: **Gaia AG** · enrollment: 470 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **BEHAVIORAL:** levidex
- **BEHAVIORAL:** Control
- **OTHER:** treatment as usual (TAU)

## Key facts

- **NCT ID:** NCT06090305
- **Lead sponsor:** Gaia AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-20
- **Primary completion:** 2024-12-06
- **Final completion:** 2024-12-06
- **Target enrollment:** 470 (ACTUAL)
- **Last updated:** 2025-01-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06090305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06090305, "Effectiveness of a Digital Health Application for Multiple Sclerosis (Levidex)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06090305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*